FCPA and Anti-Corruption for Life Science Companies

FCPA and Anti-Corruption for Life Science Companies

Monday, May 17 to Tuesday, May 18, 2010
The Helmsley Park Lane Hotel, New York, New York, United States

Jeffrey L. Antoon
Director – Financial Internal Audit
Johnson & Johnson

Ela Bochenek
Associate General Counsel – International
C.R. Bard, Inc.

Eric D. Brown
Assistant General Counsel - Global Trade Regulations
Eli Lilly and Company

Carolyn M. Bruguera
Vice President & General Counsel
Micrus Endovascular Corporation

Federico Busatta
Avvocato
Gianni, Origoni, Grippo, & Partners

Bret A. Campbell
Partner,
Cadwalader, Wickersham & Taft LLP

Christine Chung
Partner
Quinn Emanuel
(New York, NY)

Hwa Soo Chung
Chair, Health Practice Group
Kim & Chang

Jeffrey D. Clark
Partner,
Willkie Farr & Gallagher LLP

Jeffrey C. Eglash
Senior Counsel,
Litigation & Legal Policy
General Electric Company

Alice S. Fisher
Partner, Global Co-Chair,
White Collar and Government Investigations
Latham & Watkins

Daniel Freed
International Compliance Counsel,
Allergan

Daniel Garen
Chief Compliance Officer & Senior Counsel
Siemens Healthcare Sector, USA

Gary F. Giampetruzzi
Assistant General Counsel
Head of Government Investigations, Pfizer Inc

Asheesh Goel
Partner,
Ropes & Gray LLP

Richard Grime
Partner,
O’Melveny & Myers LLP

Kathleen M. Hamann
Trial Attourney, FCPA Division
Fraud Section, Criminal Division,
U.S. Department of Justice

Sandrine Hannedouche-Leric
Senior Legal Analyst
Anti-corruption Division
Directorate for Financial and Enterprise Affairs
OECD (Paris, France)

Jay Holtmeier
Partner
Wilmer Cutler Pickering Hale and Dorr LLP

David N. Kelley
Partner,
Cahill Gordon & Reindel LLP

John E. Kelly
Senior Counsel,
Fulbright & Jaworski

Daniel T. Kessler
Chief Counsel International Trade Regulation,
Pfizer Inc

Karen Lowney
Senior Director – Global Compliance
Cephalon

M. Fabiana Lacerca
Senior Vice President & Chief Compliance Officer,
Mylan Inc.

Peter Maher
Partner,
Forensic & Dispute Services
Deloitte LLP

Rosland Fisher McLeod
Vice President
Chief Compliance Officer,
Biogen Idec

Paul J. McNulty
Partner,
Baker & McKenzie

Steven S. Michaels
Counsel,
Debevoise & Plimpton LLP

Laura C. O’Donnell
Chief Compliance Counsel
G.E. Healthcare

Kirk Ogrosky
Partner
Arnold & Porter LLP (Washington, D.C.)
Recent Deputy Chief, Fraud Section
U.S. Department of Justice

Karen A. Popp
Partner,
Sidley Austin LLP

David L. Ralston
Division Counsel,
Legal Regulatory & Compliance
Abbott Laboratories

Edward A. Rial
Partner,
Forensic & Dispute Services
Deloitte Financial Advisory Services LLP

Bradley J. Tandy
Senior Vice President, General Counsel, & Secretary,
Biomet

Steven A. Tyrrell
Partner & Co-Chair of Investigations & Criminal Defense Group
Weil Gotshal & Manges LLP (Washington, D.C.)
Recent Chief of the U.S. Department of Justice’s Fraud Section

Steven Vincze
Director, Forensic & Dispute Services
Deloitte LLP

Hank Bond Walther
Deputy Chief, Fraud Section
U.S. Department of Justice

Lawrence T. Weiss
Vice President – Chief International Counsel,
Covidien

Jacqueline C. Wolff
Of Counsel,
Covington & Burling LLP

Debra Wong Yang
Partner,
Gibson, Dunn & Crutcher LLP

Elizabeth M. Zechenter, J.D., Ph.D.
Senior Counsel,
Legal Operations International
GlaxoSmithKline